Cargando…

Cellular Immune Activation in Cerebrospinal Fluid From Ugandans With Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome

Background. Human immunodeficiency virus (HIV)-associated cryptococcal meningitis (CM) is characterized by high fungal burden and limited leukocyte trafficking to cerebrospinal fluid (CSF). The immunopathogenesis of CM immune reconstitution inflammatory syndrome (IRIS) after initiation of antiretrov...

Descripción completa

Detalles Bibliográficos
Autores principales: Meya, David B., Okurut, Samuel, Zziwa, Godfrey, Rolfes, Melissa A., Kelsey, Melander, Cose, Steve, Joloba, Moses, Naluyima, Prossy, Palmer, Brent E., Kambugu, Andrew, Mayanja-Kizza, Harriet, Bohjanen, Paul R., Eller, Michael A., Wahl, Sharon M., Boulware, David R., Manabe, Yuka C., Janoff, Edward N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407762/
https://www.ncbi.nlm.nih.gov/pubmed/25492918
http://dx.doi.org/10.1093/infdis/jiu664
_version_ 1782367954850021376
author Meya, David B.
Okurut, Samuel
Zziwa, Godfrey
Rolfes, Melissa A.
Kelsey, Melander
Cose, Steve
Joloba, Moses
Naluyima, Prossy
Palmer, Brent E.
Kambugu, Andrew
Mayanja-Kizza, Harriet
Bohjanen, Paul R.
Eller, Michael A.
Wahl, Sharon M.
Boulware, David R.
Manabe, Yuka C.
Janoff, Edward N.
author_facet Meya, David B.
Okurut, Samuel
Zziwa, Godfrey
Rolfes, Melissa A.
Kelsey, Melander
Cose, Steve
Joloba, Moses
Naluyima, Prossy
Palmer, Brent E.
Kambugu, Andrew
Mayanja-Kizza, Harriet
Bohjanen, Paul R.
Eller, Michael A.
Wahl, Sharon M.
Boulware, David R.
Manabe, Yuka C.
Janoff, Edward N.
author_sort Meya, David B.
collection PubMed
description Background. Human immunodeficiency virus (HIV)-associated cryptococcal meningitis (CM) is characterized by high fungal burden and limited leukocyte trafficking to cerebrospinal fluid (CSF). The immunopathogenesis of CM immune reconstitution inflammatory syndrome (IRIS) after initiation of antiretroviral therapy at the site of infection is poorly understood. Methods. We characterized the lineage and activation status of mononuclear cells in blood and CSF of HIV-infected patients with noncryptococcal meningitis (NCM) (n = 10), those with CM at day 0 (n = 40) or day 14 (n = 21) of antifungal therapy, and those with CM-IRIS (n = 10). Results. At diagnosis, highly activated CD8(+) T cells predominated in CSF in both CM and NCM. CM-IRIS was associated with an increasing frequency of CSF CD4(+) T cells (increased from 2.2% to 23%; P = .06), a shift in monocyte phenotype from classic to an intermediate/proinflammatory, and increased programmed death ligand 1 expression on natural killer cells (increased from 11.9% to 61.6%, P = .03). CSF cellular responses were distinct from responses in peripheral blood. Conclusions. After CM, T cells in CSF tend to evolve with the development of IRIS, with increasing proportions of activated CD4(+) T cells, migration of intermediate monocytes to the CSF, and declining fungal burden. These changes provide insight into IRIS pathogenesis and could be exploited to more effectively treat CM and prevent CM-IRIS.
format Online
Article
Text
id pubmed-4407762
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-44077622015-05-15 Cellular Immune Activation in Cerebrospinal Fluid From Ugandans With Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome Meya, David B. Okurut, Samuel Zziwa, Godfrey Rolfes, Melissa A. Kelsey, Melander Cose, Steve Joloba, Moses Naluyima, Prossy Palmer, Brent E. Kambugu, Andrew Mayanja-Kizza, Harriet Bohjanen, Paul R. Eller, Michael A. Wahl, Sharon M. Boulware, David R. Manabe, Yuka C. Janoff, Edward N. J Infect Dis Major Articles and Brief Reports Background. Human immunodeficiency virus (HIV)-associated cryptococcal meningitis (CM) is characterized by high fungal burden and limited leukocyte trafficking to cerebrospinal fluid (CSF). The immunopathogenesis of CM immune reconstitution inflammatory syndrome (IRIS) after initiation of antiretroviral therapy at the site of infection is poorly understood. Methods. We characterized the lineage and activation status of mononuclear cells in blood and CSF of HIV-infected patients with noncryptococcal meningitis (NCM) (n = 10), those with CM at day 0 (n = 40) or day 14 (n = 21) of antifungal therapy, and those with CM-IRIS (n = 10). Results. At diagnosis, highly activated CD8(+) T cells predominated in CSF in both CM and NCM. CM-IRIS was associated with an increasing frequency of CSF CD4(+) T cells (increased from 2.2% to 23%; P = .06), a shift in monocyte phenotype from classic to an intermediate/proinflammatory, and increased programmed death ligand 1 expression on natural killer cells (increased from 11.9% to 61.6%, P = .03). CSF cellular responses were distinct from responses in peripheral blood. Conclusions. After CM, T cells in CSF tend to evolve with the development of IRIS, with increasing proportions of activated CD4(+) T cells, migration of intermediate monocytes to the CSF, and declining fungal burden. These changes provide insight into IRIS pathogenesis and could be exploited to more effectively treat CM and prevent CM-IRIS. Oxford University Press 2015-05-15 2014-12-09 /pmc/articles/PMC4407762/ /pubmed/25492918 http://dx.doi.org/10.1093/infdis/jiu664 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Major Articles and Brief Reports
Meya, David B.
Okurut, Samuel
Zziwa, Godfrey
Rolfes, Melissa A.
Kelsey, Melander
Cose, Steve
Joloba, Moses
Naluyima, Prossy
Palmer, Brent E.
Kambugu, Andrew
Mayanja-Kizza, Harriet
Bohjanen, Paul R.
Eller, Michael A.
Wahl, Sharon M.
Boulware, David R.
Manabe, Yuka C.
Janoff, Edward N.
Cellular Immune Activation in Cerebrospinal Fluid From Ugandans With Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome
title Cellular Immune Activation in Cerebrospinal Fluid From Ugandans With Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome
title_full Cellular Immune Activation in Cerebrospinal Fluid From Ugandans With Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome
title_fullStr Cellular Immune Activation in Cerebrospinal Fluid From Ugandans With Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome
title_full_unstemmed Cellular Immune Activation in Cerebrospinal Fluid From Ugandans With Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome
title_short Cellular Immune Activation in Cerebrospinal Fluid From Ugandans With Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome
title_sort cellular immune activation in cerebrospinal fluid from ugandans with cryptococcal meningitis and immune reconstitution inflammatory syndrome
topic Major Articles and Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407762/
https://www.ncbi.nlm.nih.gov/pubmed/25492918
http://dx.doi.org/10.1093/infdis/jiu664
work_keys_str_mv AT meyadavidb cellularimmuneactivationincerebrospinalfluidfromugandanswithcryptococcalmeningitisandimmunereconstitutioninflammatorysyndrome
AT okurutsamuel cellularimmuneactivationincerebrospinalfluidfromugandanswithcryptococcalmeningitisandimmunereconstitutioninflammatorysyndrome
AT zziwagodfrey cellularimmuneactivationincerebrospinalfluidfromugandanswithcryptococcalmeningitisandimmunereconstitutioninflammatorysyndrome
AT rolfesmelissaa cellularimmuneactivationincerebrospinalfluidfromugandanswithcryptococcalmeningitisandimmunereconstitutioninflammatorysyndrome
AT kelseymelander cellularimmuneactivationincerebrospinalfluidfromugandanswithcryptococcalmeningitisandimmunereconstitutioninflammatorysyndrome
AT cosesteve cellularimmuneactivationincerebrospinalfluidfromugandanswithcryptococcalmeningitisandimmunereconstitutioninflammatorysyndrome
AT jolobamoses cellularimmuneactivationincerebrospinalfluidfromugandanswithcryptococcalmeningitisandimmunereconstitutioninflammatorysyndrome
AT naluyimaprossy cellularimmuneactivationincerebrospinalfluidfromugandanswithcryptococcalmeningitisandimmunereconstitutioninflammatorysyndrome
AT palmerbrente cellularimmuneactivationincerebrospinalfluidfromugandanswithcryptococcalmeningitisandimmunereconstitutioninflammatorysyndrome
AT kambuguandrew cellularimmuneactivationincerebrospinalfluidfromugandanswithcryptococcalmeningitisandimmunereconstitutioninflammatorysyndrome
AT mayanjakizzaharriet cellularimmuneactivationincerebrospinalfluidfromugandanswithcryptococcalmeningitisandimmunereconstitutioninflammatorysyndrome
AT bohjanenpaulr cellularimmuneactivationincerebrospinalfluidfromugandanswithcryptococcalmeningitisandimmunereconstitutioninflammatorysyndrome
AT ellermichaela cellularimmuneactivationincerebrospinalfluidfromugandanswithcryptococcalmeningitisandimmunereconstitutioninflammatorysyndrome
AT wahlsharonm cellularimmuneactivationincerebrospinalfluidfromugandanswithcryptococcalmeningitisandimmunereconstitutioninflammatorysyndrome
AT boulwaredavidr cellularimmuneactivationincerebrospinalfluidfromugandanswithcryptococcalmeningitisandimmunereconstitutioninflammatorysyndrome
AT manabeyukac cellularimmuneactivationincerebrospinalfluidfromugandanswithcryptococcalmeningitisandimmunereconstitutioninflammatorysyndrome
AT janoffedwardn cellularimmuneactivationincerebrospinalfluidfromugandanswithcryptococcalmeningitisandimmunereconstitutioninflammatorysyndrome